160 related articles for article (PubMed ID: 8187565)
1. Immunophenotyping in acute leukaemia, myelodysplastic syndromes and hairy cell leukaemia. The use of monoclonal antibodies against myeloid differentiation antigens.
Kristensen JS
Dan Med Bull; 1994 Feb; 41(1):52-65. PubMed ID: 8187565
[No Abstract] [Full Text] [Related]
2. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.
Bonde J; Meyer K; Broe MK; Hokland M; Turley H; Hokland P
Br J Haematol; 1996 Feb; 92(2):269-79. PubMed ID: 8602985
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
4. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
5. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
Wood BL
Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
7. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
[TBL] [Abstract][Full Text] [Related]
8. Latency of onset of de novo myelodysplastic syndromes.
Wu PS; Hay AE; Thomas GE; Bowen DT
Haematologica; 2004 Nov; 89(11):1392-4. PubMed ID: 15531463
[TBL] [Abstract][Full Text] [Related]
9. Expression of differentiation and activation antigens on peripheral blood mononuclear cells in chronic lymphocytic leukaemia (CLL) and in hairy-cell leukaemia (HCL).
Pálóczi K; Demeter J; Hokland P; Petrányi GG
Eur J Haematol; 1990 Nov; 45(5):285-6. PubMed ID: 2261961
[No Abstract] [Full Text] [Related]
10. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
Merle-Béral H; Boucheix C
Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
[TBL] [Abstract][Full Text] [Related]
11. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality control group.
Basso G; Bernasconi P; Chianese R; Crovetti G; Garbaccio G; Iavarone A; Pautasso M; Santagostino A; Stacchini A;
J Biol Regul Homeost Agents; 2001; 15(2):145-55. PubMed ID: 11501972
[TBL] [Abstract][Full Text] [Related]
13. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
[TBL] [Abstract][Full Text] [Related]
14. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
15. Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
Donelli A; Chiodino C; Panissidi T; Roncaglia R; Torelli G
Haematologica; 2000 Sep; 85(9):1002-3. PubMed ID: 10980650
[No Abstract] [Full Text] [Related]
16. [10 years' experiences with flow cytometric immunological phenotyping in malignant hematologic diseases].
Kristensen JS; Hokland P
Ugeskr Laeger; 1996 Oct; 158(43):6098-102. PubMed ID: 8928296
[TBL] [Abstract][Full Text] [Related]
17. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
Haferlach T; Schoch C
Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
[No Abstract] [Full Text] [Related]
18. Immunophenotyping of AML and MDS and detection of residual disease.
Sanz MA; Sempere A
Baillieres Clin Haematol; 1996 Mar; 9(1):35-55. PubMed ID: 8730550
[TBL] [Abstract][Full Text] [Related]
19. CD5+, CD11c+, CD20+ hairy cell leukemia.
Heimann PS; Vardiman JW; Stock W; Platanias LC; Golomb HM
Blood; 1991 Apr; 77(7):1617-9. PubMed ID: 1706957
[No Abstract] [Full Text] [Related]
20. [Cytomorphology of acute myeloid leukemia and myelodysplastic syndromes].
Kuriyama K
Rinsho Ketsueki; 2006 Aug; 47(8):701-9. PubMed ID: 16986708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
